Stock 9926 AKESO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Akeso, Inc.

Equities

9926

KYG0146B1032

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-05-14 EDT 		5-day change 1st Jan Change
49.2 HKD -0.10% Intraday chart for Akeso, Inc. +2.39% +6.03%
04-24 Akeso’s Supplemental New Drug Application for Cervical Cancer Drug Accepted by Chinese Regulator MT
04-24 National Medical Products Administration Accepted the Supplemental New Drug Application by Akeso, Inc. for (Cadonilimab, Pd-1/Ctla-4) as First-Line Treatment for Cervical Cancer CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
AKESO, INC.
Bio Therapeutic Drugs
-0.10%+2.39%+6.03%+15.63% - 5.45B
Bullish
Neutral
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. 9926 Stock
  4. Charts Akeso, Inc.
  5. Comparison Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW